Pivotal Trial Design Considerations: Noninferiority vs Superiority, Device, Control Arm Anticoagulation Durations, NOAC Considerations and More – Industry and Clinician Perspectives

Presenter: Brian K. Whisenant

REGISTER for free or LOG IN to view this content

Pivotal Trial Design Considerations: Noninferiority vs Superiority, Device, Control Arm Anticoagulation Durations, NOAC Considerations and More – Industry and Clinician Perspectives

We Recommend